Sargent Bickham Lagudis LLC Rain Therapeutics Inc. Transaction History

Sargent Bickham Lagudis LLC

  • $1.22 Billion
  • Q4 2022

A detailed history of Sargent Bickham Lagudis LLC transactions in Rain Therapeutics Inc. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 1,749 shares of RAIN stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,749
Previous 2,332 25.0%
Holding current value
$0
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
SELL
$5.52 - $8.48 $3,218 - $4,943
-583 Reduced 25.0%
1,749 $0
Q3 2022

Oct 27, 2022
BUY
$4.75 - $8.01 $11,077 - $18,679
2,332 New
2,332 $11,000

Others Institutions Holding RAIN

# of Institutions
3
Shares Held
122K
Call Options Held
0
Put Options Held
0
View Full List

About Rain Therapeutics Inc.

RAIN Quotes by TradingView
  • Ticker RAIN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,837,400
  • Description
  • Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in...
More about RAIN
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email